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ABSTRACT Binding of a small molecule to a macromolecular target reduces its conformational freedom, resulting in a negative
entropy change that opposes the binding. The goal of this study is to estimate the conﬁgurational entropy change of two minor-
groove-binding ligands, netropsin and distamycin, upon binding to the DNA duplex d(CGCGAAAAACGCG)d(CGCGTTTTT-
CGCG). Conﬁgurational entropy upper bounds based on 10-ns molecular dynamics simulations of netropsin and distamycin in
solution and in complex with DNA in solution were estimated using the covariance matrix of atom-positional ﬂuctuations. The re-
sults suggest that netropsin and distamycin lose a signiﬁcant amount of conﬁgurational entropy upon binding to the DNA minor
groove. The estimated changes in conﬁgurational entropy for netropsin and distamycin are 127 J K1 mol1 and 104 J K1
mol1, respectively. Estimates of the conﬁgurational entropy contributions of parts of the ligands are presented, showing that
the loss of conﬁgurational entropy is comparatively more pronounced for the ﬂexible tails than for the relatively rigid central
body.
INTRODUCTION
The thermodynamics of binding of small molecules to DNA
double helices has been extensively investigated using ex-
perimental (1–7) and computational (8–13) approaches. Un-
derstanding the favorable and unfavorable contributions to
binding free energies from computer simulations provides
fundamental insight not directly accessible through experi-
ments and complements high-resolution x-ray crystallo-
graphic (14–17) and nuclear magnetic resonance (NMR)
(18–22) experiments. Small molecules that bind in the minor
groove of DNA are known to interfere with gene expression
at the level of transcription and replication and are of great
interest in the discovery of novel antibacterial molecules
(23–25). In the rational design of new therapeutic agents
with improved binding afﬁnity and speciﬁcity, understand-
ing the thermodynamics of DNA-drug interactions is one of
the key issues (26).
Free energies together with the corresponding enthalpies
and entropies of binding have been measured for a large
number of DNA-ligand complexes (2,4,6,7,27). However,
experimental studies usually give access only to the total
change in enthalpy and entropy associated with a given
process, but no speciﬁc information on the enthalpy and
entropy change of the ligand. To analyze the free energy
changes that accompany a binding process, investigation of
binding enthalpy and entropy contributions is needed,
because entropy-enthalpy compensation effects may cause
binding events to exhibit very similar binding free energies,
although the binding process is driven by different thermo-
dynamic forces (28–31).
Molecular dynamics (MD) simulations are well suited to
investigate the structural, dynamic, and thermodynamic prop-
erties of macromolecules (32–34). To capture the function-
ing of complex biomolecules at a molecular level, a static
representation provides limited insight, and dynamical in-
formation on a sufﬁciently long timescale is a fundamental
prerequisite (35). Signiﬁcant progress in the development of
empirical potential energy functions (force ﬁelds) and in-
creasing computer power currently allow MD simulations
on the nanosecond timescale for relatively large systems.
Thus, simulations provide an extent of sampling of the con-
ﬁgurational space that may be sufﬁcient to describe the
thermodynamic properties of these systems at equilibrium
conditions. In particular, MD simulations of nucleic acids
have been reported by several groups, demonstrating results
that reproduce the solution NMR data reasonably well (36–
38). However, theoretical studies of nucleic acids are still a
challenging problem. The reasons are that 1), nucleic acids
are highly charged systems, so an accurate treatment of elec-
trostatic (long-range) interactions in computer simulations of
these systems is essential (34,39); and 2), their structure and
dynamics are largely inﬂuenced by the speciﬁc nature and
concentration of the counterions and by the solvent proper-
ties. Consequently, simulations of nucleic acids are sensitive
not only to the quality of the force-ﬁeld parameters, but also
to the simulation setup.
Netropsin and distamycin are two naturally occurring oligo-
peptides that bind noncovalently to domains of the DNA
minor groove that are rich in adenine-thymine (AT) base pairs
(40,41). Both ligands possess a cationic propylamidinium tail
and a rigid body that is constituted of amide groups and
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methylpyrrole rings. In the case of distamycin, the rigid part
is larger and the molecule terminates with a neutral
formamide tail, whereas the body of netropsin ends with a
(likely more ﬂexible) cationic guanidinum tail (see Fig. 1 for
chemical structures). Experiments by means of x-ray crys-
tallography (14,15,17,42,43) and NMR (18,19) have been
reported that provide information on the modes of interaction
of netropsin and distamycin with the DNA minor groove.
By a combination of circular dichroism spectroscopy,
ultraviolet-absorption spectroscopy, and isothermal titration
calorimetry (1,4,7,44,45), and through theoretical studies
(8,12,46–48), the binding thermodynamics of the two li-
gands were investigated. It has been shown that the ther-
modynamics of binding depends strongly on the sequence of
the base pairs in the binding site, and that the binding of
netropsin and distamycin to the minor groove of DNA is ei-
ther enthalpy- or entropy-driven (28). Furthermore, it has been
shown that the binding afﬁnities of netropsin and distamycin
for a speciﬁc DNA sequence can be considerably different,
despite their small structural differences (7).Depending on the
speciﬁc DNA sequence, the experimental values for standard
enthalpies of binding (DH) of netropsin and distamycin
range from 67.4 kJ/mol to 36.0 kJ/mol and the standard
entropies of binding (DS) range from 78.6 J K1 mol1 to
60.3 J K1 mol1 (7). The interpretation of experimental
thermodynamic binding proﬁles of minor-groove binders
usually assumes that the contributions to the binding free en-
ergy arising from conformational changes (of both DNA and
ligands)arenegligiblecomparedtoother forcesdrivingligand-
DNA complexation (restructuring of the solvent, counter ion
release, DNA-ligand interactions, and restriction of the
rotational and translational degrees of freedom) (26). The
motivation for this assumption in the case of (1:1) DNA
minor-groove binding is that 1), the double helix is not
considerably distorted; and 2), the structure of the ligand is
basically unaltered, as observed from x-ray crystallographic
studies. Thus, the binding of a ligand to the minor groove of
DNA is usually treated as a rigid-body association, with the
unfavorable entropy contributions from the loss of rotational
and translational degrees of freedom estimated as DSot1r¼
0.21(6 0.04) kJ K1 mol1 (49,50). However, the appro-
priate estimate of the DSt1r term is debated in the current
literature (2,3,7,51), and recent experiments suggest that
netropsin and distamycin may lose different amounts of ro-
tational, translational, and conﬁgurational entropy upon for-
mation of the DNA-drug complexes (7). Neglecting the
conﬁgurational contribution seems reasonable for small and
rigid binders, but not for more ﬂexible ligands. Calculation
of the conﬁgurational entropy change of DNA is currently
not feasible computationally due to the size of the double
helix. In the following text, we therefore only consider the
entropy change due to the change in ligand ﬂexibility.
During the past decades, the calculation of accurate free-
energy differences from molecular simulations has become
possible in practice (52–59). In contrast, the reliable
estimation of entropies and entropy differences from such
simulations is still a difﬁcult task (60–72). The possibility to
estimate conﬁgurational entropy from MD trajectories was
ﬁrst proposed (using impractical internal coordinates) by
Karplus and Kushick under a quasiharmonic assumption
(60). Some years later, Schlitter introduced a heuristic for-
mula, based on Cartesian coordinates, which provides an eas-
ily applicable approach to compute an approximate (71)
upper bound to the absolute entropy of a nondiffusive system
from a simulation trajectory (63). Recently, Andricioaei and
Karplus revised the quasiharmonic approach to enable the
FIGURE 1 (A) Snapshot of the complex
of netropsin with a d((CG)2A5(CG)2)
d((CG)2T5(CG)2) DNA duplex after;1 ns
of MD simulation. (B) Chemical structure
of netropsin (upper) anddistamycin (lower)
molecules. Rectangular boxes deﬁne the
atom subgroups used to estimate conﬁgu-
rational entropies: tail 1 (t1), body (b), and
tail 2 (t2). Netropsin and distamycin mol-
ecules possess identical body (b) and tail 1
(t1) moieties (red rectangles), but differ in
tail 2 (t2) (blue rectangles). The atoms of
the central peptide bond (code4) are labeled
with a star. Reference codes for the entropy
calculations are summarized in Table 1.
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use of Cartesian coordinates (67). The alternative formula-
tions proposed by Schlitter (63) and by Andricioaei and
Karplus (67) result in very similar entropy estimates (71,73–
75). In the ﬁrst case, the diagonalization of the (mass-
weighted) covariance matrix is substituted by a determinant
calculation and the formula for the entropy of a quantum-
mechanical oscillator is replaced by an approximate heuristic
expression (which slightly overestimates the entropy upper
bound (71)). This is computationally less expensive, which is
why it is used in this work. Both methods provide approx-
imate conﬁgurational entropies because the accuracy depends
on 1), how harmonic and 2), how uncorrelated the normal
modes of the simulated molecule are. An analysis of the
quasiharmonic assumption and corrections for the anhar-
monicity and second-order correlation effects has recently
been reported (71).
The aim of this study was to investigate conﬁgurational
entropy changes of netropsin and distamycin upon binding to
the minor groove of the DNA duplex d(CGCGAAAAAC-
GCG)d(CGCGTTTTTCGCG) in a 1:1 binding mode. We
used the approach based on the covariance matrix of atomic
mass-weighted ﬂuctuations, because it allows not only the
calculation of the conﬁgurational entropy of the entire chain
but also, within a certain approximation, the calculation of
the conﬁgurational entropy for different subsets of atoms or
degrees of freedom. The same system was the subject of a
previous study on relative binding free energies of netropsin
and distamycin binding to DNA, which were estimated from
up to 2 ns of molecular dynamics simulations (12). Here, to
reach sufﬁcient sampling to estimate conﬁgurational entro-
pies, the MD simulations of netropsin and distamycin free in
solution and of their complexes with DNA were extended to
10 ns. Conﬁgurational entropies of the ligands and parts
thereof in their free and bound states are estimated. The con-
ﬁgurational entropy changes that netropsin and distamycin
undergo upon binding to the minor groove of DNA are com-
pared and discussed. Comparison with experimental changes
in enthalpy and entropy has limited value, because exper-
imental values include more than the internal contributions
(see Table 1 of Baron et al. (75)). On the other hand, esti-
mating entropies of diffusive degrees of freedom is still a
computational challenge (69). However, conﬁgurational en-
tropy contributions offer an important insight into the
binding process at the atomic level.
MATERIALS AND METHODS
Molecular dynamics simulations
Four 10-ns MD simulations were performed for netropsin and distamycin,
when free in solution and when bound to DNA. Starting from a model-built
canonical B-DNA duplex d((CG)2A5(CG)2)d((CG)2T5(CG)2) (INSIGHTII,
Accelrys, San Diego, CA), initial coordinates of a netropsin-DNA and
a distamycin-DNA complex were generated employing the structures of
netropsin and distamycin molecules from Protein Data Bank (PDB) crystal
structures 101D (15,76) and 267D (76,77), with similar (but not identical) DNA
sequences. The complexes were solvated in periodic boxes (truncated oc-
tahedra) containing 11,034 simple-point-charge (SPC) water molecules (78),
and 20 Cl and 43 Na1 ions, which correspond to an experimental salt
concentration of 110 mM NaCl. Similarly, each ligand molecule (free in
solution) was solvated in 3225 SPC water molecules and 6 Na1 and 7 Cl
ions. All simulations were carried out using the GROMOS96 simulation
package (79,80) and the GROMOS96 45A4 force ﬁeld, including recently
improved nucleic acid parameters (38). The SHAKE algorithm (81) was em-
ployed to keep all the bonds constrained to their ideal values, permitting a
2-fs time step for integration of the equations of motion using the leap-frog
algorithm (82). For the calculation of nonbonded interactions a triple-range
cut-off scheme was used. Interactions within a short-range cut-off of 0.8 nm
were calculated at every time step from a pair list that was generated every
ﬁve steps. At these time points, interactions between 0.8 and 1.4 nmwere also
calculated and kept constant between updates. The electrostatic interactions
outside the outer 1.4 nm cutoff were approximated with a reaction-ﬁeld
contribution (83) using a relative permittivity of 61 (84). To maintain
constant temperature (300 K) and pressure (1 atm) a Berendsen thermostat
and barostat were employed (85). For details on system setup, force-ﬁeld
parameters, initial equilibration, and MD simulation protocols, we refer to
our previous work (12).
Entropy calculations
Conﬁgurational entropy calculations were performed following the formu-
lation by Schlitter (63), which provides an approximate (71) upper bound to
the absolute entropy S:
S, SSchlitter ¼ 1
2
kB ln det 11
kBTe
2
Z
2 Ms
 
; (1)
where kB is Boltzmann’s constant, T the absolute temperature, e Euler9s
number, Z Planck’s constant divided by 2p,M the 3N-dimensional diagonal
matrix containing the N atomic masses of the solute atoms for which the
entropy is calculated, and s the covariance matrix of atom-positional
ﬂuctuations with the elements:
sij ¼ Æðxi  ÆxiæÞðxj  ÆxjæÞæ; (2)
where xi are the Cartesian coordinates of the atoms considered in the entropy
calculation after a least-squares ﬁt of the trajectory conﬁgurations using a
particular subset of atoms. As an additional test, conﬁgurational entropies
TABLE 1 Code deﬁnitions of the atom sets used to estimate
conﬁgurational entropy
Code Description
type
i Internal conﬁgurational entropy
ip Internal conﬁgurational entropy per particle
ﬁt and cov
all All atoms of the ligand
4 Four atoms of the peptide bond in the central body (N, H, C, O)
nh Nonhydrogen atoms of the ligand
DNA Nonhydrogen atoms of the central GAAAAAC/GTTTTTC
segment
t1 Tail 1
t2 Tail 2
t Tails (atoms of tail 1 and of tail 2)
b Body
Reference codes are deﬁned for the type of entropy calculation (type),
for the subsets of atoms used to perform the structural superposition (ﬁt),
and for the atoms included in the mass-weighted covariance matrix (cov).
See Materials and Methods section and Fig. 1 for deﬁnitions.
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were alternatively calculated following the procedure of Andricioaei and
Karplus (67) (data not reported). Resulting estimates of the conﬁgurational
entropy from the two formulations differ from each other by,2%, similar to
what has been observed in the case of reversibly folding peptides in solution
(71), for ﬂexible hydrocarbon chains (75), lipids (74), and rigid organic
molecules in water (73). Entropy calculations were performed on trajectory
structures saved every 5 ps.
To evaluate the conﬁgurational entropies, molecular conﬁgurations were
superimposed via a translational superposition of centers of mass and a ro-
tational least-squares ﬁt (86), thus excluding overall translational and ro-
tational motion from the calculation of the conﬁgurational entropy (64). This
yields an internal conﬁgurational entropy (code i) or an internal conﬁgu-
rational entropy per particle (code ip) (the former divided by the number N
of particles used to calculate the covariance matrix deﬁned in Eq. 2). Three
different sets of atoms were used to remove overall translational and ro-
tational degrees of freedom of the solute (Table 1), to verify the inﬂuence of
the subsets of atoms used for ﬁtting on the ﬁnal entropy estimates.
1. All nonhydrogen atoms of the ligand under consideration (code nh).
2. Four atoms (N, H, C, and O) of the peptide bond in the central body of
the ligand molecules (code 4). In Fig. 1, the corresponding atoms are
marked with an asterisk.
3. Nonhydrogen atoms of the central GAAAAAC/GTTTTTC segment of
the corresponding d(CGCGAAAAACGCG)d(CGCGTTTTTCGCG)
DNA duplex (code DNA).
Next to the conﬁgurational entropies of the ligands, conﬁgurational en-
tropies of subsets of atoms denoted as tail 1 (t1), tail 2 (t2), tails (t), and body
(b) (see Fig. 1) were also calculated. The subset of atoms named tails (t)
includes all the atoms of tail 1 and tail 2.
Estimated conﬁgurational entropies are referenced using the notation
Stypefit covð Þ. The code cov refers to the atoms for which the covariance matrix
is calculated, and thus deﬁnes the atoms for which an upper bound to the
entropy is calculated (nh, t1, t2, t, b). The code ﬁt indicates the atoms for
which the center of mass superposition and least-squares ﬁt of the con-
ﬁgurations of the trajectory is performed (nh, 4, DNA). The code type refers
to the type of entropy calculated (i, ip). For code deﬁnitions, see Table 1.
The decrease in entropy due to correlation in the motions of two subsets
of atoms—for example, those represented by the body (b) and tails (t)—can
be estimated (65) as
S
corr
nh ðb; tÞ ¼ SinhðbÞ1 SinhðtÞ  Sinhðb1 tÞ; (3)
where the entropy Sinh b1tð Þ (i.e., Sinh nhð Þ) includes all correlations between
the atoms in the subsets b and t, and the type and ﬁt used are the same in the
calculations of the three terms.
Entropy differences between bound and free states for each ligand were
estimated, for example, for nonhydrogen atoms (nh) as
DS
i
nhðnhÞ ¼ Sinhðnh; complexÞ  Sinhðnh; freeÞ; (4)
and represent a change in internal entropy of the ligand upon binding to
DNA. The codes complex and free refer to the bound and free simulations of
the ligand, respectively.
RESULTS AND DISCUSSION
Conformational analysis of DNA
Fig. 2 shows the time series of Watson-Crick hydrogen
bonds between the base pairs for both netropsin-DNA and
distamycin-DNA complexes and the resulting cumulative
occurrences. In the ﬁrst complex (upper panel), the hydrogen
bonds between pairs of bases are well preserved over the
whole binding site. During 10 ns of this simulation, the bases
of the binding site remain hydrogen-bonded .70% of the
time. In the case of the distamycin-DNA complex (lower
panel), Watson-Crick hydrogen bonds at the termini of the
double helix are distributed differently along the bases,
reﬂecting the structural difference of this second ligand. In
the part of the DNA binding site where the structure of tail 2
FIGURE 2 Watson-Crick hydrogen bonds along
the sequence of the primary DNA strand in
netropsin-DNA (upper panel) and distamycin-
DNA (lower panel). Time series of their occurrence
and the corresponding cumulative values are
displayed based on 10-ns MD simulations. Hydro-
gen bonds close to tail 2 of netropsin and distamycin
(schematically represented) are in gray. Hydrogen
bonds are deﬁned to have a maximum hydrogen–
acceptor distance of 0.25 nmand aminimumdonor-
hydrogen-acceptor angle of 135.
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of distamycin differs from the structure of tail 2 of netropsin
(see Fig. 1), some of the Watson-Crick hydrogen bonds oc-
cur ,50% of the simulation time. The adenine bases in the
AT base pairs near tail 2 of distamycin tend to move slightly
outward from theminor groovewithout fulﬁlling the hydrogen-
bond criterion. Nevertheless, the MD trajectories show that
the DNA double-helix geometry is well-preserved for both
ligand-DNA complexes. As is reported in other studies
(38,87), the central part of the DNA double helix is found to
be more stable than the termini. Interestingly, for the ﬁrst CG
base pair in the netropsin-DNA complex and for the last GC
base pair in the distamycin-DNA complex, the correspond-
ing time series show reversible hydrogen-bonding along the
10 ns of simulation. Time series of the Watson-Crick hy-
drogen bonds systematically show that the 45A4 GROMOS
force ﬁeld captures the correct hydrogen-bond formation
along the simulation.
The atom-positional root-mean-square deviations (RMSD)
of the nonhydrogen atoms in the central GAAAAAC/
GTTTTTC segment from the initial DNA structure remain in
the range 0.2–0.4 nm (the highest values of 0.38 nm and
0.34nmwere for netropsin anddistamycin, respectively, com-
plexed with DNA; data not shown), which are reasonable
deviations considering the size of the DNA molecules. For
the base pair atoms these values are reduced to 0.26 nm in the
netropsin-DNA complex and to 0.22 nm in the distamycin-
DNA complex. The backbone atoms deviate slightly more
from the starting structure (i.e., 0.39 nm in the netropsin-
DNA complex and 0.36 nm in the distamycin-DNA com-
plex). However, no large-scale changes in the conformation
of the DNA double helix, particularly in the geometry of the
minor groove, were observed for either of the complexes,
demonstrating suitability of the simulated trajectories for the
estimation of the conﬁgurational entropy changes of ligands
upon their binding to the DNA minor groove.
Conﬁgurational entropy of netropsin
and distamycin
For netropsin and distamycin free in solution and complexed
to DNA, Fig. 3 shows the convergence properties of 1),
internal conﬁgurational entropy Sinh nhð Þ and Si4 nhð Þ, and 2),
the relative motions between ligand and DNA SiDNA nhð Þ.
Most (99%) of the ﬁnal internal conﬁgurational entropy es-
timate Sinh nhð Þ was collected within 83% of the simulation
time for the netropsin-DNA complex and within 45% of the
simulation time for the distamycin-DNA complex. For the
ligands in their free state, 99% of Sinh nhð Þ was reached faster,
i.e., within 56% of the simulation time for netropsin and
within 31% of the simulation time for distamycin. All curves
are characterized by rapid increases in the build-up corre-
sponding to structural changes of the ligands. These stepwise
increases are more pronounced for distamycin than for
netropsin. The corresponding structural changes are reﬂected
in the atom-positional RMSD of the ligand from the starting
structure along the DNA-distamycin simulation (Fig. 4).
Fig. 4 shows the nonhydrogen atom-positional RMSD for
1), the entire netropsin and distamycin molecules when
bound to DNA, 2), their bodies, and 3), both of their tails. It
can be seen that during the simulation no large structural
changes occur in the netropsin molecule, whereas the main
structural changes in distamycin appear in the formamide tail
2 of this molecule. During the simulation, the torsion angle
between tail 2 and the body of distamycin ﬂuctuates so that
the plane of pyrrole ring of tail 2 moves out of the plane
formed by the two pyrrole rings in the body of this ligand. It
is obvious that the large conformational changes observed in
the RMSD of distamycin correlate with the jumps in entropy
build-up in Fig. 3. The conﬁgurations of the distamycin
molecule that correspond to the increases in RMSD and con-
ﬁgurational entropy are shown in Fig. 5. The changes in
distamycin tail 2 also slightly affect the conﬁguration of its
FIGURE 3 Conﬁgurational entropy per atom of ne-
tropsin (A) and distamycin (B) free in solution (thin lines)
and when bound to DNA (thick lines) calculated for
nonhydrogen atoms. Conﬁgurational entropy was esti-
mated for each ligand after removal of overall translation
and rotation using all nonhydrogen atoms (Sinh nhð Þ, solid
line) or using only four atoms of the central CO-NH
peptide bond (Si4 nhð Þ, dashed line), and after a transla-
tional superposition of centers of mass and a rotational
least-squares ﬁt using the nonhydrogen atoms of the
central GAAAAAC/GTTTTTC segment (SiDNA nhð Þ, dot-
dashed line) of the DNA duplex. The arrows point to the
ﬁrst and second rapid increases in entropy for distamycin.
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body and can be correlated with the structural changes in the
binding site of the DNA double helix in the complex, as
observed in the analysis of Watson-Crick hydrogen bonds
(see Fig. 2). For both ligands, two characteristic orientations
of tail 1 can be observed. In particular, tails of netropsin and
distamycin ﬂip between two conﬁgurations with almost per-
pendicular relative orientation of the terminal propylamidine
group (see also Fig. 5). Similar behavior can be observed for
tail 2 of netropsin.
Conﬁgurational entropy estimates for the free and bound
simulations of netropsin and distamycin are reported in Table 2.
The internal conﬁgurational entropy Sinh nhð Þ of netropsin
free in solution is 862 J K1 mol1 (28 J K1 mol1 per
atom) and is reduced to 735 J K1 mol1 (24 J K1 mol1 per
atom) upon binding. Correspondingly, for distamycin, the
internal conﬁgurational entropy Sinh nhð Þ amounts to 902
J K1 mol1 (26 J K1 mol1 per atom) and is reduced to
798 J K1 mol1 (23 J K1 mol1 per atom) upon binding to
the minor groove of DNA. The change in internal conﬁg-
urational entropy DSinh nhð Þ for the netropsin molecule thus
amounts to127 J K1 mol1 (4 J K1 mol1 per atom). In
the case of distamycin, the internal conﬁgurational en-
tropy change is slightly smaller, i.e., 104 J K1 mol1
(3 J K1 mol1 per atom).
To capture the rotational motions of the ligand complexed
to the DNA minor groove, the mass-weighted covariance
matrix of atom-positional ﬂuctuations was calculated after
ﬁtting only four atoms (of the central peptide bond in the
ligand; code 4) of the trajectory structures. This procedure
yields estimates of the conﬁgurational entropy Si4 nhð Þ, which
contains contributions from the relative rotation of the ligand
with respect to the initial structure. Most (99%) of the ﬁnal
entropy estimate Si4 nhð Þ was reached within 79% of the sim-
ulation time for the netropsin-DNA complex and within 43%
of the simulation time for the distamycin-DNA complex. For
netropsin and distamycin free in solution, the corresponding
values were reached within 48% and 36% of the simulation
time, respectively. The values of Si4 nhð Þ (see Table 2) are
expected (and found) to be comparatively higher than those
for the internal conﬁgurational entropy Sinh nhð Þ, because the
rotation of the ligand is partially sampled in the entropy
calculations. The value of Sip4 nhð Þ for netropsin when free in
solution is 32 J K1 mol1 and is reduced to 29 J K1 mol1
upon binding of the ligand to DNA. In the case of distamycin,
the resulting values of Sip4 nhð Þ are slightly lower, i.e., 29 J K1
mol1 for distamycin free in solution and 27 J K1 mol1 for
distamycin in complex with DNA. The ranking of absolute
conﬁgurational entropies and relative entropies of binding
thus remains unchanged, and the contribution of rotational
motion seems to inﬂuence the two ligands similarly.
Relative motions of the ligands with respect to DNA may
be captured from the calculations of the mass-weighted co-
variance matrix after a conﬁgurational superposition proce-
dure based on nonhydrogen atoms of the central bases
FIGURE 4 Atom-positional RMSD of ligand trajectory structures from
the initial structures along 10-ns simulations of the ligand-DNA complexes.
Time series are calculated using all nonhydrogen atoms and atom subgroups
for tail 1, tail 2, and the body (see Fig. 1).
FIGURE 5 Relative motion of distamycin inside the DNA minor groove.
Three representative snapshots of distamycin from the 10-ns simulation of
the distamycin-DNA complex are shown superimposed after least-square
ﬁtting: initial conformation (black), and conformations corresponding to the
ﬁrst (blue) and second (red) rapid increase in conﬁgurational entropy (see
arrows in Figs. 3 and 6).
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GAAAAAC/GTTTTTC of the DNA duplex (code DNA).
Resulting values SiDNA nhð Þ reported in Table 2 are higher
than the internal conﬁgurational entropies Sinh nhð Þ in which
the nonhydrogen atoms of the ligands were used in the ﬁtting
procedures. Most (99%) of the ﬁnal entropy estimate
SiDNA nhð Þ was reached within 99% of the simulation time for
netropsin-DNA and within 41% of the simulation time for
the distamycin-DNA complex. The corresponding time se-
ries (Fig. 3) display evident stepwise increases, particularly
rapid in the case of distamycin bound to DNA, which sam-
ples repeatedly new regions of its conformational space in the
ﬁrst part of the simulation. Similar conclusions can be drawn
for internal conﬁgurational entropy estimates of distamycin
bound to DNA when sampled using the ﬁtting of non-
hydrogen atoms of the ligand (Sinh nhð Þ, Si4 nhð Þ).
The changes in conﬁgurational entropy of the ligands
upon binding to the minor groove of the DNA duplex (CGC-
GAAAAACGCG)d(CGCGTTTTTCGCG) show that ne-
tropsin loses more internal conﬁgurational entropy than
distamycin upon binding. The calculated differences (Eq. 4)
are in the range of estimated rotational and translational en-
tropy differences reported in the literature (i.e., DSot1r¼
0.21(6 0.04) kJ K1 mol1) (49,50). The magnitude of
these contributions is signiﬁcant when compared to the total
binding free energies accompanying minor groove binding.
Recently reported standard free energies of binding of
netropsin and distamycin to various DNA sequences ob-
tained from ultraviolet melting and isothermal titration cal-
orimetry experiments range from39.7 kJ mol1 for binding
of netropsin to the 59-AAGTT-39 binding site to 54.0 kJ
mol1 for binding of netropsin to the 59-AAAAA-39 binding
site (7). Larger conﬁgurational entropic cost in the case of
netropsin binding to DNA may be the consequence of stron-
ger electrostatic and van der Waals interactions holding
netropsin, as compared to distamycin, more tightly in the
minor groove. Additionally, we note that netropsin contains
more rotatable bonds than distamycin, which may lead to a
larger reduction of conformational freedom upon binding to
the DNA minor groove. We note, however, that 1), exper-
imentally the conﬁgurational entropy loss is sequence-
speciﬁc and may signiﬁcantly vary depending on the DNA
base pair sequence; 2), this study does not attempt to cal-
culate conﬁgurational entropy (and its differences) for the
DNA double helix (this would require signiﬁcantly longer
simulations); 3), the entropy (and its differences) of the
diffusive solvent water molecules were not examined in this
study due to the intrinsic limitation of the Schlitter and
quasiharmonic approaches to nondiffusive systems (63,64,71);
and 4), the conﬁgurational entropies estimated are upper
bounds to the true entropy of the simulated system (63,71).
Classical molecular dynamics force ﬁelds are often based
on atomic models, in which each atom is represented by
one interaction site, with the exception of aliphatic groups,
for which the C-atom and bound H-atoms are treated as
one interaction site (38,79). This united-atom simpliﬁcation
has been shown to reproduce the properties of n-alkanes as
accurately as all-atom (i.e., including explicit aliphatic
H-atoms) force ﬁelds (88). In this study, the aliphatic hy-
drogen atoms of the ligands were treated with the united
atom model, whereas all remaining atoms were treated ex-
plicitly. To investigate the effect of hydrogen atoms on
entropy estimates, the calculations have been repeated alter-
natively including nonaliphatic hydrogen atoms (16 for
netropsin out of 47 total; 15 for distamycin out of 50 total).
This leads to slightly larger values of internal conﬁgurational
entropies (i.e., 997 and 1022 J K1 mol1 for netropsin and
distamycin, respectively, free in solution, and 853 and 903
J K1 mol1 for netropsin and distamycin, respectively, in
complexwithDNA).Of course, the per-atomweighted values
slightly decrease (the contribution of nonaliphatic hydrogen
atoms to the conﬁgurational entropy is 16% for netropsin and
13% for distamycin both free in solution and when bound
to DNA).
Conﬁgurational entropies of the subgroups
The ﬂexibility of the tails of minor groove binders is an im-
portant element of ligand-DNA recognition (48). To inves-
tigate this aspect, the atoms of the ligands were divided into
three subgroups, the body (b), tail 1 (t1) and tail 2 (t2). For
each subset, the internal conﬁgurational entropies were es-
timated. The entropy contributions from the subgroups, as
well as the entropy of the entire ligands, are presented in Fig.
6 for netropsin and distamycin. The corresponding results
are reported in Table 3. Most (99%) of the ﬁnal entropy
estimates for tail 1 and tail 2 of the ligands complexed to
DNA were reached in 85% and 75% of the simulation time
for netropsin and 50% and 38% for distamycin. The
TABLE 2 Conﬁgurational entropies of netropsin and distamycin when free in solution and when bound to the minor groove of the
DNA duplex, and corresponding conﬁgurational entropy changes upon binding
Free in solution In complex with DNA Binding
Sinh nhð Þ Si4 nhð Þ Sinh nhð Þ Si4 nhð Þ SiDNA nhð Þ DSinh nhð Þ DSi4 nhð Þ
Netropsin 862 (28) 985 (32) 735 (24) 886 (29) 1014 (33) 127 (4) 99 (3)
Distamycin 902 (26) 1036 (29) 798 (23) 953 (27) 1133 (34) 104 (3) 83 (2)
Calculated type of entropy, and subsets of atoms used in the entropy calculations and in the least-squares ﬁtting procedures, are referenced using the codes
deﬁned in Table 1. The conﬁgurational entropy differences between the free and bound forms of the ligands are calculated using Eq. 4. Per-atom entropies are
given in parentheses. All values are in J K1 mol1.
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corresponding values for the ligands free in solution are
considerably lower (i.e., 31% and 13% of the simulation time
for tail 1 and tail 2 of netropsin, and 32% and 10% of the
simulation time for tail 1 and tail 2 of distamycin). For the
more rigid body of the ligands in their free and bound forms,
99% of the ﬁnal entropy estimate was always collected
within 50% of the simulation time (i.e., within 30% and 37%
for netropsin and distamycin in complex with the DNA, and
within 44% and 15% for the ligands free in solution). Es-
timates of conﬁgurational entropy obtained for different
subgroups range from 21 J K1mol1 to 47 J K1mol1,
reﬂecting diverse ﬂexibility of the subgroups. The conﬁgu-
rational entropy of the body of both ligands Sipnh bð Þ in their
free states amounts to 24 J K1 mol1 and is reduced upon
binding to 21 JK1mol1 for netropsin and to 22 JK1mol1
for distamycin. The body of both ligands is expected (and
found) to be considerably more rigid than the corresponding
tails. Conﬁgurational entropies of tail 1 and tail 2, Sipnh(t1) and
Sipnh(t2), of netropsin free in solution are 45 and 42 J K
1
mol1, respectively. In the case of distamycin, the cor-
responding values are 47 and 30 J K1 mol1, indicating the
difference in ﬂexibility of tail 2 of the investigated mol-
ecules. Upon binding, the per-atom conﬁgurational entropies
of tail 1 and tail 2 of netropsin are both reduced to 36 J K1
mol1. For distamycin, the conﬁgurational entropy is reduced
to 40 J K1 mol1 for tail 1 and to 27 J K1 mol1 for tail 2.
The entropy changes of speciﬁc subgroups upon binding to
the minor groove can be calculated (see Materials and
Methods). Tail 1 of netropsin loses 9 J K1 mol1 of internal
conﬁgurational entropy per atom and tail 2 loses 6 J K1
mol1 per atom upon binding. Tail 1 of distamycin loses 7 J
K1 mol1 per atom and tail 2 loses 3 J K1 mol1 per atom,
respectively. The internal entropic cost for the body of the
ligand molecule DSipnh bð Þ upon binding to DNA is 3 and
2 J K1 mol1 for netropsin and distamycin, respectively.
Comparison of entropy changes in tails and body of both
ligands reveals that the highest contributions to the entropy
of binding come from the restriction in the ﬂexibility of
the ligand tails. The loss of internal conﬁgurational entropy
for the (structurally equal) body and tail 1 of the ligands is
comparable for both ligands, whereas the entropic loss of tail
2 is higher for the more ﬂexible tail of netropsin. Further-
more, in the build-up of the entropy curves for distamycin
bound to DNA (Fig. 6), the stepwise increases in the internal
conﬁgurational entropy of tail 2 corresponding to the already
mentioned structural changes in the ligand (Figs. 4 and 5)
can again be observed.
Correlation effects
It is evident that the internal conﬁgurational entropies cal-
culated for the subsets of atoms of a ligand do not add up to
the total entropy of the ligand (see Tables 2 and 3). The
correlation between the motion of the body and the tails,
FIGURE 6 Internal entropy per atom calculated for non-
hydrogen atoms of the entire ligandmolecules (Sinh nhð Þ, solid
line), and of the subgroups tail 1 (Sinh(t1), dotted line), tail 2
(Sinh(t2), dashed line), and body (S
i
nh bð Þ, dot-dashed line) for
netropsin free in solution (A) and when bound to DNA (B),
and for distamycin free in solution (C) and when bound to
DNA (D). The arrows point to the ﬁrst and second rapid
increases in entropy for distamycin (compare to Fig. 3).
TABLE 3 Internal conﬁgurational entropies of atom subgroups
of netropsin and distamycin free in solution and bound to DNA,
and correlations between their body and tails
Sinh bð Þ Sinh tð Þ Sinh(t1) Sinh(t2) Scorrnh b; tð Þ
Netropsin (free) 384 (24) 623 (41) 363 (45) 297 (42) 157
Netropsin (bound) 333 (21) 513 (34) 290 (36) 252 (36) 113
D (bound  free) 51 (3) 110 (7) 73 (9) 45 (6) 44
Distamycin (free) 393 (24) 651 (34) 372 (47) 328 (30) 145
Distamycin (bound) 354 (22) 568 (30) 316 (40) 296 (27) 122
D (bound  free) 39 (2) 83 (4) 56 (7) 32 (3) 23
Corresponding changes upon binding are also reported (D). The body and
tails of the ligands are represented in Fig. 1; Table 1 reports the reference
codes. Only nonhydrogen atoms were used in the calculations. Least-
squares superposition of structures was done using all nonhydrogen atoms.
Per-atom entropies are given in parentheses. Correlation entropy Scorrnh b; tð Þ
was calculated using Eq. 3. All values are in J K1 mol1.
Entropy Loss of Ligands upon DNA Binding 1467
Biophysical Journal 91(4) 1460–1470
Scorrnh b; tð Þ, of the ligands can thus be obtained (Eq. 3). The
differences in entropy due to correlation in the motion be-
tween the tails and the body for netropsin and distamycin in
their bound and free states are reported in the last column of
Table 3. The value of Scorrnh b; tð Þ upon binding reduces from
157 J K1 mol1 to 113 J K1 mol1 (netropsin) and from
145 to 122 J K1 mol1 (distamycin). The difference in cor-
relation between the tails and the central part of netropsin
when bound to DNA and when free in solution amounts
to -44 J K1 mol1. In the case of distamycin, the corre-
sponding difference is smaller (i.e., 23 J K1 mol1),
which is a consequence of greater ﬂexibility of netropsin
when compared to distamycin. Thus, in the latter case, the
change in correlation upon binding is smaller.
CONCLUSION
Upon binding of a ligand to the minor groove of DNA, the
translational, rotational, and internal motion of the ligand is
reduced. The entropic cost the ligand pays depends on the
speciﬁc chemical characteristics of the ligand itself and of the
DNA binding sequence. Here, the changes in conﬁgurational
entropy of netropsin and distamycin upon complex formation
with the DNA duplex d(CGCGAAAAACGCG)d(CG-
CGTTTTTCGCG) were estimated. The contribution of
internal conﬁgurational entropy loss in the ligand is generally
omitted in the analysis of the experimental binding data, since
minor groove binding does not require signiﬁcant changes in
DNAor ligand conformation. This study shows that netropsin
and distamycin ligands lose a considerable amount of internal
conﬁgurational entropy upon binding to the minor groove. In
particular, the number of conformations that are available
to the tails of the ligands becomes small upon complex
formation, consequently lowering the corresponding conﬁg-
urational entropy upper bounds. It is found that netropsin
loses more entropy upon binding than distamycin. We have
shown that internal entropy changes that occur upon binding
of netropsin and distamycin to the DNAminor groove can be
estimated on a 10-ns timescale using Schlitter’s approxima-
tion and the GROMOS 45A4 force ﬁeld. The conﬁgurational
entropy changes calculated in this work can be used in the
interpretation of minor-groove binding phenomena and can
improve the thermodynamic description and understanding of
the binding of small ligands to the minor groove of DNA.
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